This episode discusses four MMWR reports. First, nirsevimab reduces the risk of severe RSV among Alaskan Native children, who have historically experienced high rates of RSV-associated hospitalizations. Second, a concerning decline in the use of antivirals is seen among children and teens hospitalized with flu. Third, measles cases are surging worldwide as vaccination coverage remains below pre-pandemic levels. Last, disease presentation, vaccination status, and recent international travel are important when suspected measles cases occur.